VIGONVITA-B
0263018AListed醫療健康 · 苏州旺山旺水生物医药股份有限公司是一家专注于创新药物研发的生物医药公司。
High attention
79.6
/100
- Offer price
- HK$33.37
- Final offer price
- HK$33.37
- Lot / entry fee
- 200 shares · HK$7K
- Proceeds
- HK$587.2M
- Sponsor
- CITIC Securities
- Est. margin oversub.
- 4674.7x
- Public oversub.
- 6238.4x
- One-lot win rate
- 1.7%
- First-day return
- +145.7%
Offer starts
Oct 28
Offer closes
Nov 3
Grey market
Nov 5
Listing
Nov 6
AI reference scoring and scenarios
After grey market
After grey market L1 heat score
79.6/ 100
Data coverage High
Target
Historical calibration
Listing-day trend
PositivePartial basis
Up probability
91.5%
First-day reference range
+137.5% – +214.1%
Published outcome check
First-day resultBig up+145.7%
Our call: Trend call valid
Covered 18/25 core factors
UsedMissingNot yet scorableN/A
Margin oversubscription
High heatOffer size
Good qualityCornerstone lockup
—Post-lockup offer value
—Recent same-rule trend
Strong trendRecent same-type trend
Strong trendRecent sector trend
Strong trendValuation
Average appealFundamental quality
Average qualityGrowth quality
Weak qualityProfitability
Weak qualityCash runway
Weak qualityCustomer concentration
High riskCornerstone quality
—Sponsor record
Strong recordGreenshoe arrangementGreenshoe: yes · 15%
Average supportStabilizer track recordCLSA
Strong recordA-share pre-grey trend
—A-share listing-day trend
—Public oversubscription
High heatOne-lot win rate
High heatInternational placing
High heatFinal pricing position
—Actual greenshoe use
—Grey market return
Strong trendThe assessment and probability ranges are informational only and are not investment advice.
AI Research Report
After grey marketThe analysis report for this IPO is being generated.